NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 753188 | 4-chloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide | 0.0385613993886001 | 0.21520719 |
NSC 753189 | 3,5-dichloro-N-(4-(3-(4-chloro-3-methoxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)benzamide | 0.0385613993886001 | 0.17806612 |
NSC 756188 | GSK718429A | 0.0385613993886001 | 0.054362675 |
NSC 756406 | GW852849X | 0.0385613993886001 | 0.17252124 |
NSC 759018 | Null | 0.0385613993886001 | -0.022860947 |
NSC 88916 | 10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | 0.0385613993886001 | -0.14828892 |
NSC 111533 | Methoxycamptothecin | 0.0414190425892865 | 0.19458358 |
NSC 125845 | Null | 0.0414190425892865 | 0.18820387 |
NSC 131258 | Null | 0.0414190425892865 | 0.14703132 |
NSC 133072 | Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) | 0.0414190425892865 | 0.38577494 |